Trump’s Hammer Hits FDA, Moderna Falls Further and Patent Cliffs Loom February 19, 2025· 1 min read· Heather McKenzie Rare diseases Biogen and Stoke Strike Dravet Syndrome Co-Development Deal February 18, 2025· 2 min read· Dan Samorodnitsky Legal Novo Seeks $830M in Fraud Case...
Alnylam,Alnylam v. Moderna,BioNTech,IPR,Moderna,Pfizer,vaccine We previously reported on patent infringement litigations between Alnylam and Moderna. Below we provide updates on two proceedings involving the mRNA vaccine producer Moderna. First, in a patent action brought by Alnylam Pharmaceuticals, Inc...
Moderna and BioNTech are reporting 69% profit margins, with Moderna and Pfizer paying little in taxes, thePeople’s Vaccine Alliancesaid Sept. 15. Thanks topatent monopolies for COVID vaccines— development of which was supported by $100 billion in public funding from taxpayers in t...
During an earnings call that same month, Pfizer executives said they expectedroughly 24%of the U.S. population to get an annual Covid booster in 2023. But by December, only around 17% of U.S. adults had received the new Covid shots from Pfizer and Moderna, according to data from the ...
The drugmaker's shares,already downover 44% this so far this year, fell 8.7% in morning trading and were set to erase over $14 billion in market capitalization, if losses continued through the day. Shares of Moderna and Pfizer's German partner in the vaccine, BioNTech SE, fell 5% each...
When Moderna, another coronavirus mRNA vaccine that is now approved and that works very similar to the Pfizer vaccine, was just finishing its Phase I trial, The Independent wrote about the vaccine and described it this way: “It uses a sequence of genetic RNA material produced in a lab that...
Moderna wins court ruling in COVID vaccine patent spat with BioNTech, PfizerSA NewsYesterday, 11:48 AM24 Comments Generic drugmakers could see negative impact from higher Chinese tariffsSA NewsTue, Mar. 041 Comment Pfizer mulls US-led manufacturing amid tariff threatSA NewsTue, Mar. 046 Comments...
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna Fierce Pharma Thu, 03/6/25 - 10:15 pm Pfizer BioNTech Moderna Therapeutics vaccines legal patents COVID-19 Pfizer CEO says he's prepared to shift manufacturing to the U.S. amid tariff ...
All this newfound wealth and talk of Nobel Prize nominations obfuscates a very discomforting reality. Namely, while the two key companies involved in mRNA technology - Moderna and BioNTech - have made shiploads of money, they have no previous track record in creating approved drugs, let...
Pfizer has10 strategic partners and customers.Pfizer recently partnered withBioNTechonNovember 11, 2023. Date Type Business Partner Country News Snippet Sources 11/22/2023 Partner BioNTech Germany European Patent Office Invalidates Moderna’s RNA Solution ...